Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes

Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes

Ovarian cancer is the eighth most common neoplasm in women with a high mortality rate mainly due to a marked propensity for peritoneal spread directly at diagnosis, as well as tumor recurrence after radical surgical treatment. Treatments for peritoneal metastases have to be designed from a patient’s...

Full description

Bibliographic Details
Main Authors: Daniele Marrelli, Luca Ansaloni, Orietta Federici, Salvatore Asero, Ludovico Carbone, Luigi Marano, Gianluca Baiocchi, Marco Vaira, Federico Coccolini, Andrea Di Giorgio, Massimo Framarini, Roberta Gelmini, Carmen Palopoli, Fabio Accarpio, Anna Fagotti
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
advanced ovarian cancer
peritoneal metastases
neoadjuvant chemotherapy
hyperthermic intraperitoneal chemotherapy
cytoreductive surgery
Online Access:https://www.mdpi.com/2072-6694/14/23/6010

Similar Items

Similar Items